Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can more frequent speech therapy sessions help children speak clearly faster?

NCT ID NCT07779759

Disease control Sponsor: University Ghent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether a high-intensity speech therapy program—five 30-minute sessions per week—works better than the traditional low-intensity approach of two sessions per week for children aged 4 to 12 with phonological speech sound disorders. The study will measure improvements in speech clarity, quality of life, and cost-effectiveness. The goal is to provide solid evidence on the optimal therapy intensity to help children achieve understandable speech more efficiently.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
High-intensity combined phonetic-phonological speech therapy
What this could lead to
If high-intensity therapy proves more effective and cost-effective, it could change standard practice, helping children speak more clearly in a shorter time.
What could go wrong
This is a relatively small trial, and results may not apply to all children. More frequent sessions could be harder for families to manage, and the therapy may not be cost-effective in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 4 and 12 years * Presence of at least one phonological speech sound disorder. Exclusion Criteria: * Presence of a language disorder * Presence of hearing disorders * Presence of neurological or neuromuscular disorders * Presence of craniofacial anomalies (e.g., a cleft palate)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Phonological (speech) disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

articulation disorder communication disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Phonological (speech) disorder Speech disorders in children Speech therapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital Ghent

    RECRUITING

    Ghent, 9000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.